BioKeralty Research Institute is part of Keralty group’s research, development and innovation (R&D&I) division. Following the Keralty’s health model principles, BioKeralty drives and coordinates research and development projects in several health areas. The main research areas are: chronic diseases, regenerative medicine, cancer, personalized medicine or digital health, as well as health value, social care and community care.
Thought its participation in several partnerships, R&D&I projects and related calls, Keralty group works in the implementation of attention models, management models and health technologies and tools. In this way, Keralty aims to create competitive advantage that will allow the group share and add value to its patients and health professionals.
BioKeralty news BioKeralty searches for innovative solutions able to optimize the manufacture of cornea substitutes The initiative is part of the Nanogrow project which seeks to shorten manufacturing times and increase the effectiveness and tolerance of autograft In the image, lipid nanoparticles…
BioKeralty news NanoGSkin reduces grafting time thanks to a regenerative approach The project points out that the clinical application of generated artificial skin would improve significantly patients’ survival and life quality The image shows the absence of dermal histopathological conditions. December 15…
For those people interested in the scientific publications and patents developed by the BioKeralty team, this section gathers detailed information and useful references corresponding to its scientific research.
Nanomaterials, biomedical applications, in vitro and in vivo antimicrobial activities, nanomedicine, fatty acids, nanofibrous membranes, tissue reparations, etc. constitute some of the research topics included in this section.
Primary care
Cancer
Chronic and neurodegenerative
Infectious diseases
E-health
Genomics and personalized
Regenerative medicine
Nanotechnology
Education
Community
Social
Health value